earnings
EV
NYSE · EVMN
Evommune, Inc.
Healthcare · Biotechnology
$6.65
Down-$0.04 (-0.60%)
Updated Oct 6, 2026, 10:38 PM
SID Score
2.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 261.72M
- P/E ratio
- -21.13
- Dividend yield
- 0.00%
- 52-week range
- $6.52 – $29.07
- Volume
- 1.37M
- Avg. volume
- 205.5K
Price performance · EVMN
EVMN price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
EVMN closed at $6.65 after 20 trading sessions, down 49.16% for the selected period.
- Last close
- $6.65
- Period change
- -49.16%
- Period low
- $6.65
- Period high
- $13.08
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $6.86 | $7.2164 | $6.52 | $6.65 | 1.37M |
| Oct 2, 2026 | $7.25 | $7.28 | $6.74 | $6.92 | 1.75M |
| Oct 1, 2026 | $8.25 | $8.30 | $6.99 | $7.21 | 1.53M |
| Sep 30, 2026 | $8.40 | $8.525 | $8.11 | $8.26 | 724.2K |
| Sep 29, 2026 | $8.36 | $8.65 | $8.11 | $8.35 | 807.6K |
| Sep 28, 2026 | $8.40 | $8.435 | $8.12 | $8.39 | 660.79K |
| Sep 25, 2026 | $8.78 | $8.78 | $8.33 | $8.49 | 542.05K |
| Sep 24, 2026 | $8.73 | $8.90 | $8.25 | $8.80 | 992.27K |
| Sep 23, 2026 | $9.48 | $9.54 | $8.69 | $8.77 | 872.39K |
| Sep 22, 2026 | $9.45 | $9.865 | $9.3916 | $9.60 | 573.82K |
| Sep 21, 2026 | $9.70 | $9.70 | $9.35 | $9.45 | 603.02K |
| Sep 18, 2026 | $9.39 | $9.75 | $9.20 | $9.65 | 1.49M |
| Sep 17, 2026 | $9.57 | $9.67 | $9.35 | $9.37 | 405.81K |
| Sep 16, 2026 | $9.98 | $9.99 | $9.3006 | $9.37 | 568.86K |
| Sep 15, 2026 | $10.43 | $10.43 | $9.80 | $9.99 | 520K |
| Sep 14, 2026 | $10.49 | $10.6259 | $10.31 | $10.43 | 350.2K |
| Sep 11, 2026 | $10.66 | $10.82 | $10.50 | $10.54 | 388.92K |
| Sep 10, 2026 | $10.50 | $11.03 | $10.31 | $10.56 | 692.62K |
| Sep 9, 2026 | $11.90 | $12.10 | $10.3001 | $10.84 | 3.99M |
| Sep 8, 2026 | $12.11 | $13.35 | $12.01 | $13.08 | 1.24M |
Latest EVMN news
The latest Smart Investors Daily articles mentioning EVMN.
Stock researchResearch & News · Competitors
Company
Market Activity
Research & News
Loading stock research…

